Abstract
The atherosclerosis-related cardiovascular diseases, such as coronary artery disease, stroke and peripheral artery disease, are the leading cause of death and morbidity in the United States and Europe. The pathophysiology of atherosclerotic plaque is essential to understand the criticality of these diseases and the correct functioning of pharmacological strategies. The use of statins, both primary and secondary prevention, it is well established in clinical practice based on scientific evidence; however, the use of aspirin in primary prevention is widely debated.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
